Parallel Advisors, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 83 filers reported holding SEELOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$156
-84.6%
8490.0%0.00%
Q2 2023$1,015
+72.9%
8490.0%0.00%
Q1 2023$587
+1.9%
8490.0%0.00%
Q4 2022$576
-42.4%
8490.0%0.00%
Q3 2022$1,0000.0%8490.0%0.00%
Q2 2022$1,0000.0%8490.0%0.00%
Q1 2022$1,0000.0%8490.0%0.00%
Q4 2021$1,000
-50.0%
8490.0%0.00%
Q3 2021$2,0000.0%8490.0%0.00%
Q2 2021$2,000
-50.0%
8490.0%0.00%
Q1 2021$4,0008490.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders